Preparation of Zwitterionic Polypeptides and Biomedical Application
Huayu Tian,Xiuwen Guan,Yanhui Li,Zixue Jiao,Xuesi Chen
2013-01-01
Abstract:SUMMARY A novel drug delivery system was developed by electrostatic binding of pH-sensitive charge conversional PEI-poly (L-lysine)-poly (glutamic acid) (PELG), polyethylenimine (PEI) and pHsensitive modified doxorubicin (DOX). DOX was confirmed to be efficiently delivered into cancer cells, and the PELG/PEI/CAD system showed higher drug release and endocytosis in lower pH (tumor tissues), which would lead to higher killing effect on cancer cells. INTRODUCTION Polyethylenimine (PEI) has been widely used for gene delivery. Branched PEI with molecular weight of 25kDa (PEI25K) was regarded as the benchmark for gene carriers. 1, 2 There have been a lot of reports about PEI/DNA complexes for gene delivery, and positively charged PEI can also be used for delivering negatively charged proteins and drugs. 3, 4 Inspired by this, we tried to use PEI to adsorb negatively charged cis-aconityl doxorubicin (CAD). However, the strong interaction and nonspecific phagocytosis caused by negatively charged macromolecules in vivo would make the positively charged PEI/CAD complex hard to arrive in target tissues. So the PEI/CAD complex was further shielded by pHsensitive zwitterionic polypeptide PELG to form PELG/PEI/CAD complex. The ternary complex was negatively charged in normal tissues, when arriving in acidic tumor area, PELG turned to positively charged and broke away from the complex. Then the positive charges on the complex surface would be beneficial to adhere to the cell membrane and enter cells by endocytosis. In further acidic environment (endosomes and lysosomes), the pH-sensitive cleavable CAD would turn back to DOX and kill the cancer cells. EXPERIMENTAL METHODS The PELG was synthesized by ring opening polymerization. Firstly, the N-carboxyanhydride of ε-benzyloxycarbonyl-Llysine (Lys (Z)-NCA) and N-carboxyanhydride of γ-benzyl-Lglutamate (BLG-NCA) were synthesized. Secondly, PEI, Lys (Z)-NCA and BLG-NCA were dissolved in dried chloroform and stirred for 72 h at 30 °C. After reaction, the mixture was deposited with excess diethyl ether. After filtration, PEI-poly (benzyloxycarbonyl-Llysine)-poly (benzyl-L-glutamate) (PEI-PLys (Z)-PBLG) was dried. The benzyloxycarbonyl and benzyl of protected PEI-PLys (Z)-PBLG were removed to obtain PELG. The synthesis of CAD was conducted by dissolving certain amount of DOX and cisaconitic anhydride (CA) in DMF, stirred for 24 h at 25 °C in dark. After reaction, the product was extracted and obtained by lyophilization. The PELG/PEI/CAD complex solution was prepared by mixing PEI and CAD aqueous solution together and vortex. After incubation, PELG was added to the previous solution to obtain PELG/PEI/CAD ternary complex. The zeta potentials of the complexes were measured by zeta potential/BI-90Plus particle size analyzer. In vitro drug release behavior was also studied. The cytotoxicities of complexes were assessed with methyl thiazolyl tetrazolium (MTT) assay. Cell uptake studies were carried out by flow cytometry (FCM) and confocal laser scanning microscopy (CLSM). RESULTS AND DISCUSSION The 1 H NMR and GPC results demonstrated that the PELG was successfully synthesized. CAD was characterized by 1 H NMR, FT-IR spectra and mass spectrometry (MS). The zeta potential study showed the PELG/PEI/CAD complexes were negatively charged in pH 7.4, while in acidic pH (pH 6.8, 6.4 and 5.8), they were positively charged (+22.1~+25.7 mV), which would help to interact with negatively charged cell membranes, leading to higher cell uptake efficiency. The cumulative drug release of PELG/PEI/CAD complexes increased with the pH decreasing (Figure 1). In pH 7.4, about 49.2% drug released in 24 h, and the cumulative drug release reached to 69.9% in pH 6.4. In acidic environment the pH-sensitive cis-aconityl linkage of CAD could be cleaved and DOX would be released. 0 5 10 15 20 25 20 30 40 50 60 70 80 C u m u la ti v e R el ea se ( % )